Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure

Milton Packer, Jose Meller, Norma Medina, Madeline Yushak

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The hemodynamic effects of oral captopril and intravenous nitroprusside were compared in 15 patients with severe chronic congestive heart failure. At doses of both drugs titrated so as to produce similar decreases in systemic vascular resistance in each patient, nitroprusside produced substantially greater increases in cardiac index (+0.67 versus +0.31 liters/min/m2, p <0.01) but smaller decreases in mean arterial pressure (-18.4 versus -11.0 mm Hg, p <0.01) than did captopril. This finding was due to a significant decrease in heart rate with captopril (-7 beats/min, p <0.01) which was not seen with nitroprusside, since changes in stroke volume index with both drugs were similar. Nitroprusside produced a decrease in pulmonary arteriolar resistance quantitatively similar to the decrease in systemic vascular resistance, but the decrease in pulmonary arteriolar resistance with captopril was not significant. Despite similar decreases in systemic resistance, captopril produced a greater decrease in left ventricular filling pressure (-10.2 versus -6.9 mm Hg, p <0.01) but a smaller decrease in mean right atrial pressure (-3.1 versus -5.3 mm Hg, p <0.01) than did nitroprusside. Thus, captopril has actions independent of its systemic vasodilator effects which account for the quantitative differences observed in its hemodynamic responses compared with those of nitroprusside in patients with severe chronic heart failure. These differences support experimental evidence that angiotensin, in addition to its direct systemic arterial vasoconstrictor actions, exerts positive chronotropic effects and alters ventricular compliance but has minimal direct effects on the limb venous circulation and on the pulmonary vasculature.

Original languageEnglish (US)
Pages (from-to)183-188
Number of pages6
JournalThe American Journal of Cardiology
Volume51
Issue number1
DOIs
StatePublished - Jan 1 1983

Fingerprint

Captopril
Nitroprusside
Heart Failure
Hemodynamics
Vascular Resistance
Lung
Pulmonary Circulation
Atrial Pressure
Angiotensins
Vasoconstrictor Agents
Ventricular Pressure
Vasodilator Agents
Pharmaceutical Preparations
Stroke Volume
Compliance
Arterial Pressure
Extremities
Heart Rate

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure. / Packer, Milton; Meller, Jose; Medina, Norma; Yushak, Madeline.

In: The American Journal of Cardiology, Vol. 51, No. 1, 01.01.1983, p. 183-188.

Research output: Contribution to journalArticle

Packer, Milton ; Meller, Jose ; Medina, Norma ; Yushak, Madeline. / Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure. In: The American Journal of Cardiology. 1983 ; Vol. 51, No. 1. pp. 183-188.
@article{a0a601a37f6d451d8ba6bfb0a5ca7d06,
title = "Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure",
abstract = "The hemodynamic effects of oral captopril and intravenous nitroprusside were compared in 15 patients with severe chronic congestive heart failure. At doses of both drugs titrated so as to produce similar decreases in systemic vascular resistance in each patient, nitroprusside produced substantially greater increases in cardiac index (+0.67 versus +0.31 liters/min/m2, p <0.01) but smaller decreases in mean arterial pressure (-18.4 versus -11.0 mm Hg, p <0.01) than did captopril. This finding was due to a significant decrease in heart rate with captopril (-7 beats/min, p <0.01) which was not seen with nitroprusside, since changes in stroke volume index with both drugs were similar. Nitroprusside produced a decrease in pulmonary arteriolar resistance quantitatively similar to the decrease in systemic vascular resistance, but the decrease in pulmonary arteriolar resistance with captopril was not significant. Despite similar decreases in systemic resistance, captopril produced a greater decrease in left ventricular filling pressure (-10.2 versus -6.9 mm Hg, p <0.01) but a smaller decrease in mean right atrial pressure (-3.1 versus -5.3 mm Hg, p <0.01) than did nitroprusside. Thus, captopril has actions independent of its systemic vasodilator effects which account for the quantitative differences observed in its hemodynamic responses compared with those of nitroprusside in patients with severe chronic heart failure. These differences support experimental evidence that angiotensin, in addition to its direct systemic arterial vasoconstrictor actions, exerts positive chronotropic effects and alters ventricular compliance but has minimal direct effects on the limb venous circulation and on the pulmonary vasculature.",
author = "Milton Packer and Jose Meller and Norma Medina and Madeline Yushak",
year = "1983",
month = "1",
day = "1",
doi = "10.1016/S0002-9149(83)80033-2",
language = "English (US)",
volume = "51",
pages = "183--188",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure

AU - Packer, Milton

AU - Meller, Jose

AU - Medina, Norma

AU - Yushak, Madeline

PY - 1983/1/1

Y1 - 1983/1/1

N2 - The hemodynamic effects of oral captopril and intravenous nitroprusside were compared in 15 patients with severe chronic congestive heart failure. At doses of both drugs titrated so as to produce similar decreases in systemic vascular resistance in each patient, nitroprusside produced substantially greater increases in cardiac index (+0.67 versus +0.31 liters/min/m2, p <0.01) but smaller decreases in mean arterial pressure (-18.4 versus -11.0 mm Hg, p <0.01) than did captopril. This finding was due to a significant decrease in heart rate with captopril (-7 beats/min, p <0.01) which was not seen with nitroprusside, since changes in stroke volume index with both drugs were similar. Nitroprusside produced a decrease in pulmonary arteriolar resistance quantitatively similar to the decrease in systemic vascular resistance, but the decrease in pulmonary arteriolar resistance with captopril was not significant. Despite similar decreases in systemic resistance, captopril produced a greater decrease in left ventricular filling pressure (-10.2 versus -6.9 mm Hg, p <0.01) but a smaller decrease in mean right atrial pressure (-3.1 versus -5.3 mm Hg, p <0.01) than did nitroprusside. Thus, captopril has actions independent of its systemic vasodilator effects which account for the quantitative differences observed in its hemodynamic responses compared with those of nitroprusside in patients with severe chronic heart failure. These differences support experimental evidence that angiotensin, in addition to its direct systemic arterial vasoconstrictor actions, exerts positive chronotropic effects and alters ventricular compliance but has minimal direct effects on the limb venous circulation and on the pulmonary vasculature.

AB - The hemodynamic effects of oral captopril and intravenous nitroprusside were compared in 15 patients with severe chronic congestive heart failure. At doses of both drugs titrated so as to produce similar decreases in systemic vascular resistance in each patient, nitroprusside produced substantially greater increases in cardiac index (+0.67 versus +0.31 liters/min/m2, p <0.01) but smaller decreases in mean arterial pressure (-18.4 versus -11.0 mm Hg, p <0.01) than did captopril. This finding was due to a significant decrease in heart rate with captopril (-7 beats/min, p <0.01) which was not seen with nitroprusside, since changes in stroke volume index with both drugs were similar. Nitroprusside produced a decrease in pulmonary arteriolar resistance quantitatively similar to the decrease in systemic vascular resistance, but the decrease in pulmonary arteriolar resistance with captopril was not significant. Despite similar decreases in systemic resistance, captopril produced a greater decrease in left ventricular filling pressure (-10.2 versus -6.9 mm Hg, p <0.01) but a smaller decrease in mean right atrial pressure (-3.1 versus -5.3 mm Hg, p <0.01) than did nitroprusside. Thus, captopril has actions independent of its systemic vasodilator effects which account for the quantitative differences observed in its hemodynamic responses compared with those of nitroprusside in patients with severe chronic heart failure. These differences support experimental evidence that angiotensin, in addition to its direct systemic arterial vasoconstrictor actions, exerts positive chronotropic effects and alters ventricular compliance but has minimal direct effects on the limb venous circulation and on the pulmonary vasculature.

UR - http://www.scopus.com/inward/record.url?scp=0020664515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020664515&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(83)80033-2

DO - 10.1016/S0002-9149(83)80033-2

M3 - Article

C2 - 6336876

AN - SCOPUS:0020664515

VL - 51

SP - 183

EP - 188

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 1

ER -